Literature DB >> 19139376

Intrarenal dopaminergic system regulates renin expression.

Ming-Zhi Zhang1, Bing Yao, Xiaofeng Fang, Suwan Wang, James P Smith, Raymond C Harris.   

Abstract

Dopamine is a major regulator of proximal tubule salt reabsorption and is a modulator of renin release. Dopamine has been reported to stimulate renin release in vitro through activation of D1-like receptors. However, previous studies investigating dopamine regulation of renin release in vivo have provided contradictory results, indicating stimulation, inhibition, or no effect. We have reported previously that macula densa cyclooxygenase-2 (COX-2) is suppressed by dopamine. Because macula densa COX-2 stimulates renal renin expression, our current studies investigated dopamine regulation of renal renin release and synthesis in vivo. Acute treatment with a D1-like receptor agonist, fenoldopam, significantly inhibited renin release, as did acute inhibition of proximal tubule salt reabsorption with acetazolamide. In catechol-O-methyl transferase knockout (COMT(-/-)) mice, which have increased kidney dopamine levels because of deletion of the major intrarenal dopamine metabolizing enzyme, there was attenuation in response to a low-salt diet of the increases of renal cortical COX-2 and renin expression and renin release. A high-salt diet led to significant decreases in renal renin expression but much less significant decreases in COMT(-/-) mice than wild type mice, resulting in higher renal renin expression in COMT(-/-) mice. In high salt-treated wild-type mice or COX-2 knockout mice on a normal salt diet, fenoldopam stimulated renal renin expression. These results suggest that dopamine predominantly inhibits renal renin expression and release by inhibiting macula densa COX-2, but suppression of renal cortical COX-2 activity reveals a contrasting effect of dopamine to stimulate renal renin expression through activation of D1-like receptors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139376      PMCID: PMC2680004          DOI: 10.1161/HYPERTENSIONAHA.108.127035

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  34 in total

1.  Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous gamma-L-glutamyl-L-dopa.

Authors:  D P Worth; J N Harvey; J Brown; A Worral; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

2.  Inhibition of the renin--aldosterone axis and of prolactin secretion during pregnancy by L-dopa.

Authors:  H Kaulhausen; T Oney; G Leyendecker
Journal:  Br J Obstet Gynaecol       Date:  1982-06

3.  Dissociation between renal prostaglandin E2 and renin release. Effects of glucagon, dopamine and cyclic AMP in dogs.

Authors:  A Vikse; J Bugge; E Dahl; F Kiil
Journal:  Acta Physiol Scand       Date:  1985-12

4.  Studies with fenoldopam, a dopamine receptor DA1 agonist, in essential hypertension.

Authors:  J N Harvey; D P Worth; J Brown; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1986-01       Impact factor: 4.335

5.  Resistance to salt-induced hypertension in catechol-O-methyltransferase-gene-disrupted mice.

Authors:  Teemu Helkamaa; Pekka T Männistö; Pekka Rauhala; Zhong Jian Cheng; Piet Finckenberg; Marko Huotari; Joseph A Gogos; Maria Karayiorgou; Eero M Mervaala
Journal:  J Hypertens       Date:  2003-12       Impact factor: 4.844

6.  Differential regulation of renin and Cox-2 expression in the renal cortex of C57Bl/6 mice.

Authors:  Charlotte Wagner; Helga Vitzthum; Hayo Castrop; Karl Schumacher; Michael Bucher; Sybille Albertin; Thomas M Coffman; William J Arendshorst; Armin Kurtz
Journal:  Pflugers Arch       Date:  2003-09-19       Impact factor: 3.657

Review 7.  Cyclooxygenase-2 and the renal renin-angiotensin system.

Authors:  R C Harris; M-Z Zhang; H-F Cheng
Journal:  Acta Physiol Scand       Date:  2004-08

8.  Effect of intrarenal administration of dopamine on renin release in conscious dogs.

Authors:  H Mizoguchi; V J Dzau; L G Siwek; A C Barger
Journal:  Am J Physiol       Date:  1983-01

9.  The effect of oral fenoldopam (SKF 82526-J), a peripheral dopamine receptor agonist, on blood pressure and renal function in normal man.

Authors:  J N Harvey; D P Worth; J Brown; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

10.  The effect of carbidopa and indomethacin on the renal response to gamma-L-glutamyl-L-dopa in normal man.

Authors:  R F Jeffrey; T M MacDonald; K Marwick; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

View more
  29 in total

Review 1.  Tubular control of renin synthesis and secretion.

Authors:  Jurgen Schnermann; Josephine P Briggs
Journal:  Pflugers Arch       Date:  2012-06-05       Impact factor: 3.657

2.  Activation of D4 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells.

Authors:  Ken Chen; Kun Deng; Xiaoyan Wang; Zhen Wang; Shuo Zheng; Hongmei Ren; Duofen He; Yu Han; Laureano D Asico; Pedro A Jose; Chunyu Zeng
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

3.  Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury.

Authors:  Shilin Yang; Bing Yao; Yunfeng Zhou; Huiyong Yin; Ming-Zhi Zhang; Raymond C Harris
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-14

Review 4.  Dopamine, the kidney, and hypertension.

Authors:  Raymond C Harris; Ming-Zhi Zhang
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

Review 5.  Dopamine receptors: important antihypertensive counterbalance against hypertensive factors.

Authors:  Chunyu Zeng; Pedro A Jose
Journal:  Hypertension       Date:  2010-11-22       Impact factor: 10.190

Review 6.  "I don't get no respect": the role of chloride in acute kidney injury.

Authors:  Joshua L Rein; Steven G Coca
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-12

7.  Assessing the application of tissue microarray technology to kidney research.

Authors:  Ming-Zhi Zhang; Yinghao Su; Bing Yao; Wei Zheng; Mark Decaestecker; Raymond C Harris
Journal:  J Histochem Cytochem       Date:  2010-01-19       Impact factor: 2.479

8.  Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.

Authors:  Ming-Zhi Zhang; Bing Yao; Suwan Wang; Xiaofeng Fan; Guanqing Wu; Haichun Yang; Huiyong Yin; Shilin Yang; Raymond C Harris
Journal:  J Clin Invest       Date:  2011-06-23       Impact factor: 14.808

9.  Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model.

Authors:  Ming-Zhi Zhang; Xin Wang; Haichun Yang; Agnes B Fogo; Brian J Murphy; Robert Kaltenbach; Peter Cheng; Bradley Zinker; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2017-07-24       Impact factor: 10.121

10.  Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway.

Authors:  Bing Yao; Raymond C Harris; Ming-Zhi Zhang
Journal:  Hypertension       Date:  2009-09-21       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.